Literature DB >> 30530288

MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.

Chao Ding1, Huiming Yu2, Chenlei Shi1, Tiefeng Shi1, Huadong Qin3, Yunfu Cui4.   

Abstract

Thyroid cancer keeps rapidly increasing worldwide and the most frequent type is papillary thyroid carcinoma (PTC). MicroRNAs (miRNAs) are proved dysregulated in many types of malignancies, including thyroid cancer. Although miR-let-7e has been implicated in several types of cancer regulation, relatively little is known about the function of miR-let-7e in PTC. In this study, we showed that the overexpression of miR-let-7e or knockdown of high mobility group box 1 (HMGB1) inhibited cell migration and invasion. MiR-let-7e downregulates HMGB1 expression by directly targeting the HMGB1 3'-UTR. Furthermore, HMGB1 reintroduction reversed the anti-proliferation, anti-migration, and anti-invasion roles of miR-let-7e. miR-let-7e might function as a tumor suppressor in papillary thyroid carcinoma through HMGB1. Therefore, our study demonstrates that miR-let-7e plays an important role in papillary thyroid carcinoma progression and might represent a new potential therapeutic target for treatment.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  High mobility group box 1; Papillary thyroid carcinoma; miR-let-7e; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30530288     DOI: 10.1016/j.biopha.2018.11.057

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

2.  miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.

Authors:  Ning Hu; Yanhua Tian; Yanmei Song; Leilei Zang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

3.  Long non-coding RNA LINC00704 promotes cell proliferation, migration, and invasion in papillary thyroid carcinoma via miR-204-5p/HMGB1 axis.

Authors:  Yihui Lin; Jianjia Jiang
Journal:  Open Life Sci       Date:  2020-08-12       Impact factor: 0.938

4.  Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and 131I resistance of thyroid carcinoma cells through PI3K/Akt activation.

Authors:  Wanzhi Chen; Jichun Yu; Rong Xie; Tao Zhou; Chengfeng Xiong; Shuyong Zhang; Meijun Zhong
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

5.  Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.

Authors:  Chunyu Huang; Shuiying Tang; Dong Shen; Xiangzhao Li; Li Liang; Yanqing Ding; Bihong Xu
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

Review 6.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 7.  Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.

Authors:  Aysegul Dalmizrak; Ozlem Dalmizrak
Journal:  Front Bioeng Biotechnol       Date:  2022-09-26

Review 8.  Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.

Authors:  Myriem Boufraqech; Naris Nilubol
Journal:  Cancers (Basel)       Date:  2019-12-10       Impact factor: 6.639

Review 9.  Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome.

Authors:  María Julia Lamberti; Annunziata Nigro; Vincenzo Casolaro; Natalia Belén Rumie Vittar; Jessica Dal Col
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.